BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 44 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 20,000,000 | $8,393,000 | 3.53% |
| INHERENT GROUP, LP | 39,500,000 | $15,990,000 | 2.52% |
| Affinity Asset Advisors, LLC | 10,000,000 | $4,237,000 | 1.79% |
| Diameter Capital Partners LP | 69,500,000 | $27,974,000 | 1.42% |
| DeepCurrents Investment Group LLC | 39,355,000 | $18,072,000 | 0.72% |
| Context Capital Management, LLC | 16,458 | $6,726,000 | 0.48% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $2,052,000 | 0.41% |
| Aequim Alternative Investments LP | 31,000,000 | $13,135,000 | 0.40% |
| ARISTEIA CAPITAL, L.L.C. | 29,316,000 | $12,421,000 | 0.22% |
| Orbimed Advisors | 30,000,000 | $12,150,000 | 0.22% |